Press release
Fecal Microbiota Transplantation (FMT) Market Key Drivers, Size, Trends, Growth, Outlook 2024-2033
Fecal Microbiota Transplantation (FMT) Market Key Drivers
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19430&type=smp
According to The Business Research Company's, The fecal microbiota transplantation (FMT) market size has grown strongly in recent years. It will grow from $0.80 billion in 2023 to $0.85 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to growing awareness of gut microbiome, expanding therapeutic applications, increasing personalized medicine, adoption in gastroenterology practices, increasing number of clinical trials and increasing funding and investments.
The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing incidence of clostridium difficile infections (CDI), rising prevalence of inflammatory bowel diseases, increasing research and development activities, rising geriatric population, and expanding healthcare infrastructure. Major trends in the forecast period include the development of standardized protocols for donor screening, stool preparation, advances in microbiome analysis, improved stool processing technologies, novel delivery methods, and the development of synthetic or standardized microbiota-based products.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/fecal-microbiota-transplantation-fmt-global-market-report
Market Drivers and Trends:
The rising prevalence of gastrointestinal disorders is expected to propel the growth of the fecal microbiota transplantation (FMT) market going forward. Gastrointestinal (GI) disorders refer to a wide range of conditions that affect the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine (colon), and anus. The rise in gastrointestinal disorders is due to increased stress, sedentary lifestyles, and higher consumption of processed foods. Fecal microbiota transplantation is used in gastrointestinal disorders to restore healthy gut bacteria, particularly for treating recurrent Clostridioides difficile infections. For instance, in 2023, according to Crohn's and Colitis Canada, a Canada-based non-profit organization, the number of people in Canada with IBD is increasing rapidly, from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (1 every 48 minutes), and by 2035, this will rise to 14,000 (1 every 38 minutes). Therefore, the rising prevalence of gastrointestinal disorders drives the growth of the fecal microbiota transplantation (FMT) market.
Major companies operating in the fecal microbiota transplantation (FMT) market are focusing on developing innovative solutions, such as microbiota-based live biotherapeutics, to enhance treatment efficacy for gastrointestinal disorders. Microbiota-based live biotherapeutics refer to live microorganisms used as therapeutic agents to restore or modify the gut microbiome for treating various diseases. For instance, in November 2022, Ferring Pharmaceuticals, a Switzerland-based biopharmaceutical company, received US Food and Drug Administration (FDA) approval for REBYOTA (fecal microbiota, live-jslm), a novel first-in-class microbiota-based live biotherapeutic indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older, following antibiotic treatment for recurrent CDI. REBYOTA is indicated for preventing Clostridioides difficile (C. difficile) infection recurrence in individuals 18 years of age and older following antibiotic treatment for recurrent CDI.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc., Finch Therapeutics Group Inc., Locus Biosciences, Yeda Research and Development Co. Ltd., Microbiotica Limited, CosmosID Inc., AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope
Fecal Microbiota Transplantation (FMT) Market 2024 Key Insights:
• The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%.
• Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Transplantation (FMT) Market
• Innovative Advancements In Fecal Microbiota Transplantation Enhanced Market Growth
• North America was the largest region in the fecal microbiota transplantation (FMT) market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=19430&type=smp
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fecal Microbiota Transplantation (FMT) Market Key Drivers, Size, Trends, Growth, Outlook 2024-2033 here
News-ID: 3760635 • Views: …
More Releases from The Business research company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for FMT
Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Trans …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Fecal Microbiota Transplantation (FMT) Market Size By 2025?
In recent times, there has been a substantial expansion in the size of the fecal microbiota transplantation (FMT) market. The market value is predicted to rise from $0.85 billion in 2024 to $0.91 billion in 2025, with…
Fecal Microbiota Transplantation (FMT) Market: Expected to Reach US$ 1.83 Bn by …
𝐅𝐞𝐜𝐚𝐥 𝐌𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐭𝐚 𝐓𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭𝐚𝐭𝐢𝐨𝐧 (𝐅𝐌𝐓) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬??
FMT has rapidly gained traction over the past decade, thanks to its demonstrated efficacy and safety in treating gastrointestinal conditions. Randomized clinical trials have shown that FMT is a highly effective therapy, with the National Institutes of Health reporting a 91% cure rate in patients who did not respond to other medical treatments. This high success rate…
Fecal Microbiota Transplantation (FMT) Market Revenue Growth Regional Share Anal …
Fecal Microbiota Transplantation (FMT) Market Report Scope:
This insightful report delves into the diverse facets of the market, providing a comprehensive scope that covers key segments, emerging trends, and potential growth areas. With a detailed analysis of market dynamics, the report offers valuable insights into the present and future landscape of the industry.
Get Full Report: https://www.maximizemarketresearch.com/market-report/global-fecal-microbiota-transplantation-fmt-market/91371/
Fecal Microbiota Transplantation (FMT) Market Research Methodology:
Our research methodology employs a robust approach, combining qualitative…
Global and United States Fecal Microbiota Transplantation (FMT) Market to Witnes …
The Fecal Microbiota Transplantation(FMT) research report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant market key players are also enlisted in order to deliver readers with in-depth analysis about industry strategies.
The…
Aerobridge Market by Manufacturers: ADELTE, FMT, HÜBNER, JBT AeroTech, thyssenk …
Aerobridge Market research report aids accomplish the needs of businesses for which it analyses the market from top to bottom by considering plentiful parameters. A strong research methodology used here consists of data models that include market overview and guide, vendor positioning grid, market time line analysis, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. The Aerobridge Market report first…
Aerobridge Market to Witness Huge Growth by 2026 | ADELTE, FMT, HBNER, AeroTech
Global (United States, European Union and China) Aerobridge Market Research Report 2019-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global (United States, European Union and China) Aerobridge Market. Some of the key players…
